← Back to Search

Contingency Management for Smoking Cessation

N/A
Recruiting
Led By Benjamin Toll
Research Sponsored by Medical University of South Carolina
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 18 or older
Be older than 18 years old
Must not have
non-English speaking
unstable psychiatric/medical conditions such as suicidal ideation, acute psychosis, or dementia
Timeline
Screening 3 weeks
Treatment Varies
Follow Up three and six months after surgery date
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a new way to help people stop smoking before surgery.

Who is the study for?
This trial is for adult smokers diagnosed with or suspected to have operable cancer, who are about to undergo surgery. Participants must smoke at least one cigarette daily and speak English. Those using alternative nicotine products, pregnant women, or individuals with unstable psychiatric/medical conditions cannot join.
What is being tested?
The study tests a new smoking cessation treatment against standard care in cancer patients facing surgery. Half will receive the novel treatment plus counseling and nicotine patches; the other half will get only the standard therapy.
What are the potential side effects?
Potential side effects may include irritation from the nicotine patch and discomfort from withdrawal symptoms such as cravings, irritability, difficulty concentrating, increased appetite, and disturbed sleep.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not speak English.
Select...
I do not have any severe mental health issues like thoughts of suicide, psychosis, or dementia.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~three and six months after surgery date
This trial's timeline: 3 weeks for screening, Varies for treatment, and three and six months after surgery date for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Abstinence Rates as assessed by self-report for past 7 days, Carbon Monoxide Breath Monitoring and/or Anabasine testing

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Contingency ManagementExperimental Treatment1 Intervention
Group II: Standard CareActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Contingency Management
2014
Completed Phase 4
~3440

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,958 Previous Clinical Trials
41,112,298 Total Patients Enrolled
Medical University of South CarolinaLead Sponsor
979 Previous Clinical Trials
7,400,712 Total Patients Enrolled
Benjamin TollPrincipal Investigator - Medical University of South Carolina
Medical University of South Carolina
1 Previous Clinical Trials
40 Total Patients Enrolled

Media Library

Contingency Management Clinical Trial Eligibility Overview. Trial Name: NCT04605458 — N/A
Smoking Cessation Research Study Groups: Contingency Management, Standard Care
Smoking Cessation Clinical Trial 2023: Contingency Management Highlights & Side Effects. Trial Name: NCT04605458 — N/A
Contingency Management 2023 Treatment Timeline for Medical Study. Trial Name: NCT04605458 — N/A
~31 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top